LEX-WK-1K95KG5Bcrawled 2025-02-18 12:55Z
Biosimilars at the Crossroads: A $234 Billion Opportunity or a Missed Chance for Healthcare Savings?
Jake Rosvold · Aydin H. Harston · Biosimilars Law Bulletin · Published February 18, 2025
Work details
- author
- Jake Rosvold · Aydin H. Harston
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Health Care and Life Sciences
- published
- 2025-02-18
Citation
Jake Rosvold, Aydin H. Harston, Biosimilars at the Crossroads: A $234 Billion Opportunity or a Missed Chance for Healthcare Savings?, Biosimilars Law Bulletin (February 18, 2025) [The Library at LexBlog, LEX-WK-1K95KG5B, lexpid.org/1K95KG5B]